PEGylation of interleukin-10 for the mitigation of enhanced pain states

The anti-inflammatory cytokine interleukin-10 (IL-10) shows promise for the treatment of neuropathic pain, but for IL-10 to be clinically useful as a short-term therapeutic its duration needs to be improved. In this study, IL-10 was covalently modified with polyethylene glycol (PEG) with the goal of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Soderquist, Ryan G., Milligan, Erin D., Harrison, Jacqueline A., Chavez, Raymond A., Johnson, Kirk W., Watkins, Linda R., Mahoney, Melissa J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3604983/
https://ncbi.nlm.nih.gov/pubmed/19768789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm.a.32611
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller